Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

Sponsor

Cancer Research UK (Other)

Overall Status

Unknown status

CT.gov ID

NCT00757614

Collaborator

(none)

14,000

Enrollment

Location

Study Details

Study Description

Brief Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This study is looking at genetic susceptibility to cancer and interactions between genes and the environment in patients with cancer in East Anglia, Trent, or West Midlands of the United Kingdom.

Condition or Disease	Intervention/Treatment	Phase
Bladder Cancer Brain and Central Nervous System Tumors Esophageal Cancer Intraocular Melanoma Kidney Cancer Lymphoma Melanoma (Skin) Pancreatic Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter	Genetic: DNA analysis Genetic: polymorphism analysis Other: laboratory biomarker analysis Other: questionnaire administration

Detailed Description

OBJECTIVES:

To obtain epidemiological information and biological material on a population-based series of cancer cases, including malignant melanoma, lymphoma, bladder, kidney, esophageal, and pancreatic cancer, and brain tumors.
Identify novel cancer susceptibility genes, by comparison of genotype frequencies in cases with the corresponding frequencies in large control series.
To estimate the age and sex-specific risks associated with variants in predisposition genes.
To evaluate interactions between polymorphisms in predisposition genes and potential lifestyle risk factors.

OUTLINE: This is a multicenter study.

Patients complete a detailed epidemiological questionnaire that includes information on education, occupation, smoking habits, alcohol consumption, height, weight, reproductive history (age at menarche, age at pregnancies, parity, and age at menopause), oral contraceptive use, hormone replacement therapy use, family history of cancer, and past medical history.

Blood samples are collected from patients. DNA is extracted from these blood samples, from samples collected from cancer-free control participants in MREC-SEARCH-CONTROL, and from additional controls through the European Prospective Investigation of Cancer (EPIC) study (a population-based study of diet and health based in Norfolk, East Anglia). DNA samples are analyzed for polymorphisms of low penetrance cancer susceptibility genes.

In addition to the cancer patients recruited for this study, patients with breast, ovarian, endometrial, colorectal, and prostate cancer are recruited for the following related clinical trials: MREC-SEARCH-BREAST, MREC-SEARCH-OVARIAN, MREC-SEARCH-ENDOMETRIAL, MREC-SEARCH-COLORECTAL, and MREC-SEARCH-PROSTATE.

Study Design

Study Type:

Observational

Anticipated Enrollment :

14000 participants

Official Title:

A Population Based Study of Genetic Predisposition and Gene-Environment Interactions in Cancer in East Anglia, Trent and West Midlands

Study Start Date :

Feb 1, 2008

Outcome Measures

Primary Outcome Measures

Acquisition of epidemiological information and biological material []
Identification of novel cancer susceptibility genes []
Estimation of the age and sex-specific risks associated with variants in predisposition genes []
Evaluation of interactions between polymorphisms in predisposition genes and potential lifestyle risk factors []

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 69 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

DISEASE CHARACTERISTICS:

Diagnosed with bladder cancer, kidney cancer, esophageal cancer, pancreatic cancer, brain cancer, malignant melanoma, or lymphoma within the past 5 years
Identified through the Cancer Research Network OR through the cancer registry serving any of the following geographic regions of the United Kingdom:
East Anglia
West Midlands
Trent